{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:20:59Z","timestamp":1784888459900,"version":"3.55.0"},"reference-count":58,"publisher":"American Association for Cancer Research (AACR)","issue":"3","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":97,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173166"],"award-info":[{"award-number":["82173166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372886"],"award-info":[{"award-number":["82372886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472475 and 82273282"],"award-info":[{"award-number":["81472475 and 82273282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103414"],"award-info":[{"award-number":["82103414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nature Science Foundation of CHongqing","award":["cstc2021jcyj-msxmX0015 and CSTB2022NSCQ-MSX0783"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0015 and CSTB2022NSCQ-MSX0783"]}]},{"name":"Chongqing Medical Scientific Research Project\/Joint Project of Chongqing Health Commission and Science and Technology Bureau","award":["NO.2021MSXM033 and 2023QNXM039"],"award-info":[{"award-number":["NO.2021MSXM033 and 2023QNXM039"]}]},{"name":"Chongqing Graduate Tutor Team Construction Project, Chongqing Education Commission Foundation","award":["cqmudstd202216"],"award-info":[{"award-number":["cqmudstd202216"]}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["W0094"],"award-info":[{"award-number":["W0094"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The limited infiltration of CD8+ T cells in tumors hampers the effectiveness of T cell\u2013based immunotherapy, yet the mechanisms that limit tumor infiltration by CD8+ T cells remain unclear. Through bulk RNA sequencing of human tumors, we identified a strong correlation between WNT7A expression and reduced CD8+ T-cell infiltration. Further investigation demonstrated that inhibiting WNT7A substantially enhanced MHC-I expression on tumor cells. Mechanistically, WNT7A inhibition inactivated the Wnt\/\u03b2-catenin signaling pathway and thus resulted in reduced physical interaction between \u03b2-catenin and p65 in the cytoplasm, which increased the nuclear translocation of p65 and activated the NF-\u03baB pathway, ultimately promoting the transcription of genes encoding MHC-I molecules. We found that our lead compound, 1365-0109, disrupted the protein\u2013protein interaction between WNT7A and its receptor FZD5, resulting in the upregulation of MHC-I expression. In murine tumor models, both genetic and pharmaceutical suppression of WNT7A led to increased MHC-I levels on tumor cells, and consequently enhanced the infiltration and functionality of CD8+ T cells, which bolstered antitumor immunity and improved the effectiveness of immune checkpoint blockade therapy. These findings have elucidated the intrinsic mechanisms of WNT7A-induced immune suppression, suggesting that therapeutic interventions targeting WNT7A hold promise for enhancing the efficacy of immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2326-6066.cir-24-0484","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:25:37Z","timestamp":1738920337000},"page":"400-416","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy"],"prefix":"10.1158","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7281-9077","authenticated-orcid":false,"given":"Jiazheng","family":"Sun","sequence":"first","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-5280","authenticated-orcid":false,"given":"Pin","family":"Wang","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"3Department of General Surgery, The Third People\u2019s Hospital of Chengdu, Chengdu, China."},{"name":"4Center of Breast and Thyroid Surgery, The Third People\u2019s Hospital of Chengdu, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-5212","authenticated-orcid":false,"given":"Ziying","family":"Yi","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"5Department of Breast and Thyroid Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-2593","authenticated-orcid":false,"given":"Yushen","family":"Wu","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"6Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-5550","authenticated-orcid":false,"given":"Yuxian","family":"Wei","sequence":"additional","affiliation":[{"name":"2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5122-2485","authenticated-orcid":false,"given":"Huiying","family":"Fang","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"7Department of Breast Disease, Chongqing University Cancer Hospital, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4091-4455","authenticated-orcid":false,"given":"Daqiang","family":"Song","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2520-9541","authenticated-orcid":false,"given":"Yuru","family":"Chen","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2419-1731","authenticated-orcid":false,"given":"Huimin","family":"Du","sequence":"additional","affiliation":[{"name":"6Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5950-4612","authenticated-orcid":false,"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"8Department of Respiratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9590-3987","authenticated-orcid":false,"given":"Qin","family":"Li","sequence":"additional","affiliation":[{"name":"9Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-7288","authenticated-orcid":false,"given":"Dejuan","family":"Yang","sequence":"additional","affiliation":[{"name":"2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0158-421X","authenticated-orcid":false,"given":"Guosheng","family":"Ren","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-5235","authenticated-orcid":false,"given":"Hongzhong","family":"Li","sequence":"additional","affiliation":[{"name":"1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"2026042015182876600_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41577-023-00884-8","article-title":"Localization, tissue biology and T cell state\u2014implications for cancer immunotherapy","volume":"23","author":"Schenkel","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2026042015182876600_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026042015182876600_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"2026042015182876600_bib4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41416-023-02361-4","article-title":"Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities","volume":"129","author":"Wang","year":"2023","journal-title":"Br J Cancer"},{"key":"2026042015182876600_bib5","doi-asserted-by":"crossref","first-page":"e2101672","DOI":"10.1002\/advs.202101672","article-title":"Targeted anti-tumor immunotherapy using tumor infiltrating cells","volume":"8","author":"Xie","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"2026042015182876600_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1158\/2159-8290.CD-19-0790","article-title":"Directing traffic: how to effectively drive T cells into tumors","volume":"10","author":"Anandappa","year":"2020","journal-title":"Cancer Discov"},{"key":"2026042015182876600_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ctrv.2018.08.010","article-title":"Tumor-associated macrophages in breast cancer: innocent bystander or important player?","volume":"70","author":"Qiu","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"2026042015182876600_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"2026042015182876600_bib9","doi-asserted-by":"crossref","first-page":"e002591","DOI":"10.1136\/jitc-2021-002591","article-title":"Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies","volume":"9","author":"Nishikawa","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026042015182876600_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"2026042015182876600_bib11","doi-asserted-by":"crossref","first-page":"102329","DOI":"10.1016\/j.coi.2023.102329","article-title":"Tumor immune evasion through loss of MHC class-I antigen presentation","volume":"83","author":"Sari","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"2026042015182876600_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41423-021-00634-7","article-title":"HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy","volume":"18","author":"Anderson","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2026042015182876600_bib13","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1158\/1078-0432.CCR-21-3501","article-title":"The challenges of HLA class I loss in cancer immunotherapy: facts and hopes","volume":"28","author":"Aptsiauri","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2026042015182876600_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1146\/annurev-biochem-011520-102754","article-title":"HLAs, TCRs, and KIRs, a triumvirate of human cell-mediated immunity","volume":"89","author":"Djaoud","year":"2020","journal-title":"Annu Rev Biochem"},{"key":"2026042015182876600_bib15","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1038\/s41467-022-32384-z","article-title":"Molecular basis of MHC I quality control in the peptide loading complex","volume":"13","author":"Domnick","year":"2022","journal-title":"Nat Commun"},{"key":"2026042015182876600_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026042015182876600_bib17","doi-asserted-by":"crossref","first-page":"2201625","DOI":"10.1183\/13993003.01625-2022","article-title":"Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension","volume":"61","author":"Chakraborty","year":"2023","journal-title":"Eur Respir J"},{"key":"2026042015182876600_bib18","doi-asserted-by":"crossref","first-page":"100228","DOI":"10.1016\/j.labinv.2023.100228","article-title":"Role of stromal fibroblast-induced WNT7A associated with cancer cell migration through the AKT\/CLDN1 signaling axis in oral squamous cell carcinoma","volume":"103","author":"Kayamori","year":"2023","journal-title":"Lab Invest"},{"key":"2026042015182876600_bib19","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.1038\/ncomms10305","article-title":"Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness","volume":"7","author":"Avgustinova","year":"2016","journal-title":"Nat Commun"},{"key":"2026042015182876600_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41368-024-00279-y","article-title":"WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7\/JAK1\/STAT3 signaling","volume":"16","author":"Huang","year":"2024","journal-title":"Int J Oral Sci"},{"key":"2026042015182876600_bib21","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2026042015182876600_bib22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"2026042015182876600_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"2026042015182876600_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2018.05.018","article-title":"PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation","volume":"430","author":"Li","year":"2018","journal-title":"Cancer Lett"},{"key":"2026042015182876600_bib25","first-page":"1","article-title":"CyTOF measurement of immunocompetence across major immune cell types","volume":"82","author":"Subrahmanyam","year":"2017","journal-title":"Curr Protoc Cytom"},{"key":"2026042015182876600_bib26","doi-asserted-by":"crossref","first-page":"155710","DOI":"10.1016\/j.cyto.2021.155710","article-title":"QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model","volume":"148","author":"Al-Gayyar","year":"2021","journal-title":"Cytokine"},{"key":"2026042015182876600_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1535-6108(02)00154-X","article-title":"beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer","volume":"2","author":"Deng","year":"2002","journal-title":"Cancer Cell"},{"key":"2026042015182876600_bib28","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/ijc.25455","article-title":"\u03b2-Catenin and NF-\u03baB cooperate to regulate the uPA\/uPAR system in cancer cells","volume":"128","author":"Moreau","year":"2011","journal-title":"Int J Cancer"},{"key":"2026042015182876600_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"2026042015182876600_bib30","doi-asserted-by":"crossref","first-page":"eabm4459","DOI":"10.1126\/science.abm4459","article-title":"Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders","volume":"375","author":"Martin","year":"2022","journal-title":"Science"},{"key":"2026042015182876600_bib31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cell.2016.08.058","article-title":"Probing T-cell infiltration in tumors","volume":"7","author":"Sowell","year":"2016","journal-title":"Cell"},{"key":"2026042015182876600_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2026042015182876600_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-017-0534-8","article-title":"The crosstalk between autophagic and endo-\/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses","volume":"10","author":"You","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2026042015182876600_bib34","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.3390\/ijms25168773","article-title":"The Wdr5-H3K4me3 epigenetic axis regulates pancreatic tumor immunogenicity and immune suppression","volume":"25","author":"Deng","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026042015182876600_bib35","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"2026042015182876600_bib36","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat Immunol"},{"key":"2026042015182876600_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2026042015182876600_bib38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"2026042015182876600_bib39","doi-asserted-by":"crossref","first-page":"114136","DOI":"10.1016\/j.addr.2022.114136","article-title":"Leveraging macrophages for cancer theranostics","volume":"183","author":"Liu","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"2026042015182876600_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41423-021-00742-4","article-title":"Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy","volume":"19","author":"Huppert","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"2026042015182876600_bib41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-\u03baB: blending metabolism, immunity, and inflammation","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol"},{"key":"2026042015182876600_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2026042015182876600_bib43","doi-asserted-by":"crossref","first-page":"e2025840118","DOI":"10.1073\/pnas.2025840118","article-title":"Activation of NF-\u03baB and p300\/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042015182876600_bib44","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20210139","article-title":"Inhibitory feedback control of NF-\u03baB signalling in health and disease","volume":"478","author":"Prescott","year":"2021","journal-title":"Biochem J"},{"key":"2026042015182876600_bib45","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.apsb.2022.12.001","article-title":"A novel IRAK4\/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR\/MYD88-mediated NF-\u03baB pathway","volume":"13","author":"Yoon","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"2026042015182876600_bib46","first-page":"155","article-title":"Cross-regulation between Wnt and NF-\u03baB signaling pathways","volume":"1","author":"Du","year":"2010","journal-title":"For Immunopathol Dis Therap"},{"key":"2026042015182876600_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026042015182876600_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","article-title":"Combination strategies to maximize the benefits of cancer immunotherapy","volume":"14","author":"Zhu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"2026042015182876600_bib49","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"2026042015182876600_bib50","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jamaoncol.2018.7147","article-title":"Current landscape of immunotherapy in breast cancer: a review","volume":"5","author":"Adams","year":"2019","journal-title":"JAMA Oncol"},{"key":"2026042015182876600_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2022.11.014","article-title":"Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma","volume":"56","author":"Wu","year":"2023","journal-title":"Immunity"},{"key":"2026042015182876600_bib52","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1158\/1535-7163.MCT-20-0825","article-title":"Blocking Wnt\/\u03b2-catenin signal amplifies anti-PD-1 therapeutic efficacy by inhibiting tumor growth, migration, and promoting immune infiltration in glioblastomas","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2026042015182876600_bib53","doi-asserted-by":"crossref","first-page":"eabc6424","DOI":"10.1126\/sciimmunol.abc6424","article-title":"Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape","volume":"6","author":"Takeuchi","year":"2021","journal-title":"Sci Immunol"},{"key":"2026042015182876600_bib54","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jtho.2022.05.014","article-title":"Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class I antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC","volume":"17","author":"Nguyen","year":"2022","journal-title":"J Thorac Oncol"},{"key":"2026042015182876600_bib55","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/2159-8290.CD-20-0812","article-title":"Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade","volume":"11","author":"Gu","year":"2021","journal-title":"Cancer Discov"},{"key":"2026042015182876600_bib56","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1158\/2159-8290.CD-20-0913","article-title":"Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity","volume":"11","author":"Mahadevan","year":"2021","journal-title":"Cancer Discov"},{"key":"2026042015182876600_bib57","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1038\/s41467-021-27349-7","article-title":"Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance","volume":"12","author":"Deng","year":"2021","journal-title":"Nat Commun"},{"key":"2026042015182876600_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s43018-021-00280-y","article-title":"Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer","volume":"3","author":"Shen","year":"2022","journal-title":"Nat Cancer"}],"container-title":["Cancer Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerimmunolres\/article-pdf\/doi\/10.1158\/2326-6066.CIR-24-0484\/3540062\/cir-24-0484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerimmunolres\/article-pdf\/13\/3\/400\/3545260\/cir-24-0484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerimmunolres\/article-pdf\/13\/3\/400\/3545260\/cir-24-0484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:18:50Z","timestamp":1776712730000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerimmunolres\/article\/13\/3\/400\/752015\/Blocking-WNT7A-Enhances-MHC-I-Antigen-Presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,11,27]]},"published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1158\/2326-6066.cir-24-0484","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2326-6066.28531472","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531460","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531454","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531475","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531463","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531451","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531469","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531457","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531478","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2326-6066.28531466","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2326-6066.c.7702670","asserted-by":"object"}]},"ISSN":["2326-6066","2326-6074"],"issn-type":[{"value":"2326-6066","type":"print"},{"value":"2326-6074","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}